Impact of PD-1 Blockade on Severity of COVID-19 in Patients with Lung Cancers

Jia Luo, H. Rizvi, J. Egger, I. Preeshagul, J. Wolchok, M. Hellmann

Cancer discovery, 2020

In 69 patients with lung cancer who developed COVID-19, disease severity and mortality were high, but prior PD-1 blockade was not a risk factor for poor outcomes in this group, suggesting the therapy should be used when indicated.

Cited by 119 publications.

Field of study: Medicine

10.1158/2159-8290.CD-20-0596